Literature DB >> 8461282

Tranylcypromine withdrawal phenomena.

M T Halle1, S C Dilsaver.   

Abstract

The gradual or abrupt withdrawal of tranylcypromine can result in syndromes ranging in severity from mild discomfort to incapacitation. Five patients were subjected to the withdrawal of tranylcypromine. Vignettes describing the withdrawal syndrome experienced by these patients are presented. These patients suffered from severe depression or impairment of cognition in association with a reduction in their daily dose of tranylcypromine. The authors conclude that reductions in a patient's dose or the discontinuation of tranylcypromine warrant the careful supervision of a physician.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461282      PMCID: PMC1188476     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  8 in total

1.  Symptoms of major depression: acute effect of withdrawing antidepressants.

Authors:  M H Halle; V J Del Medico; S C Dilsaver
Journal:  Acta Psychiatr Scand       Date:  1991-03       Impact factor: 6.392

Review 2.  Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiology.

Authors:  S C Dilsaver
Journal:  Acta Psychiatr Scand       Date:  1988-07       Impact factor: 6.392

Review 3.  Antidepressant withdrawal syndromes: phenomenology and pathophysiology.

Authors:  S C Dilsaver; J F Greden; R M Snider
Journal:  Int Clin Psychopharmacol       Date:  1987-01       Impact factor: 1.659

4.  Antidepressant withdrawal syndromes: evidence for supersensitivity of cholinergic system as an etiologic factor.

Authors:  S C Dilsaver; J F Greden
Journal:  J Clin Psychopharmacol       Date:  1983-10       Impact factor: 3.153

Review 5.  Antidepressant withdrawal syndromes: evidence supporting the cholinergic overdrive hypothesis.

Authors:  S C Dilsaver; Z Kronfol; J C Sackellares; J F Greden
Journal:  J Clin Psychopharmacol       Date:  1983-06       Impact factor: 3.153

Review 6.  Antidepressant withdrawal phenomena.

Authors:  S C Dilsaver; J F Greden
Journal:  Biol Psychiatry       Date:  1984-02       Impact factor: 13.382

7.  Antidepressant withdrawal symptoms treated with anticholinergic agents.

Authors:  S C Dilsaver; M Feinberg; J F Greden
Journal:  Am J Psychiatry       Date:  1983-02       Impact factor: 18.112

Review 8.  Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena.

Authors:  S C Dilsaver
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1990       Impact factor: 5.067

  8 in total
  4 in total

1.  Tranylcypromine withdrawal: is it more common than we realize?

Authors:  N C Briggs
Journal:  J Psychiatry Neurosci       Date:  1994-11       Impact factor: 6.186

2.  Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.

Authors:  Filippo Bogetto; Silvio Bellino; Raffaele Bonatto Revello; Luca Patria
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy.

Authors:  Richard C. Shelton
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-08

Review 4.  Antidepressant discontinuation syndromes.

Authors:  P M Haddad
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.